MENU
+Compare
NKTR
Stock ticker: NASDAQ
AS OF
Jun 6, 04:59 PM (EDT)
Price
$0.67
Change
-$0.00 (-0.00%)
Capitalization
1.86B

NKTR Nektar Therapeutics Forecast, Technical & Fundamental Analysis

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NKTR with price predictions
Jun 05, 2025

NKTR in upward trend: 10-day moving average broke above 50-day moving average on May 30, 2025

The 10-day moving average for NKTR crossed bullishly above the 50-day moving average on May 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on NKTR as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NKTR just turned positive on May 28, 2025. Looking at past instances where NKTR's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

NKTR moved above its 50-day moving average on May 28, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTR advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 122 cases where NKTR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 58 cases where NKTR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NKTR broke above its upper Bollinger Band on June 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NKTR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: NKTR's P/B Ratio (135.135) is slightly higher than the industry average of (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). NKTR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (1.601) is also within normal values, averaging (263.647).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NKTR is expected to report earnings to fall 18.21% to -19 cents per share on August 07

Nektar Therapeutics NKTR Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
The last earnings report on May 08 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 2.04M shares outstanding, the current market capitalization sits at 1.86B.
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCEKF0.15N/A
+2.41%
Bear Creek Mining Corp.
TELNY15.440.10
+0.68%
Telenor ASA
ESPRX36.78N/A
N/A
Allspring Special Small Cap Value R6
EVSIX24.27N/A
N/A
Allspring Disciplined US Core Inst
UOLGY18.97-0.98
-4.91%
UOL Group Ltd.

NKTR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-9.59%
CRSP - NKTR
51%
Loosely correlated
+1.37%
IPSC - NKTR
48%
Loosely correlated
-0.71%
RXRX - NKTR
47%
Loosely correlated
-7.13%
CRNX - NKTR
46%
Loosely correlated
+0.59%
ARWR - NKTR
46%
Loosely correlated
-1.73%
More